Document is current
Any future updates will be listed below
-
Authors
Kurihara, Sota https://orcid.org/0009-0002-2415-3311
Ishikawa, Akihiro https://orcid.org/0000-0002-7692-3851
Kaneko, Shin https://orcid.org/0000-0003-2291-4586
- License Information
-
More Information
Article History
Received: 5 February 2024
Accepted: 6 March 2024
First Online: 18 April 2024
Declarations
:
: Not applicable.
: Not applicable.
: Shin Kaneko is a founder, shareholder, and scientific adviser of Shinobi Therapeutics Inc., and received research funding from Takeda Pharmaceutical Co. Ltd., Astellase Co., Ltd., Terumo Co. Ltd., and Shinobi Therapeutics Inc.
